![{[Name]}](/probes/images/structure-default.jpg?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/2353410-13-4.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/2030118-14-8.gif?v=2025011501)
Inquiry Basket
Azido-PEG3-acid | CAS 1056024-94-2
| Catalog Number | R14-0288 |
| Category | Azides |
| Molecular Formula | C9H17N3O5 |
| Molecular Weight | 247.25 |
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
Azido-PEG3-acid is a PEG-based PROTAC linker used in the synthesis of PROTACs. It is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Chemical Information
Product Specification
Computed Properties
Patents
| Related CAS | 1167575-20-3 (polymer) |
| Synonyms | Azide-PEG3-Carboxylic acid;N3-PEG3-COOH; Azido-PEG3-C2-acid; N3-PEG3-CH2CH2COOH; Azido-PEG3-propionic acid; 12-Azido-4,7,10-trioxadodecanoic acid; Propanoic acid, 3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]- |
| Purity | ≥95% |
| IUPAC Name | 3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]propanoic acid |
| Canonical SMILES | C(COCCOCCOCCN=[N+]=[N-])C(=O)O |
| InChI | InChI=1S/C9H17N3O5/c10-12-11-2-4-16-6-8-17-7-5-15-3-1-9(13)14/h1-8H2,(H,13,14) |
| InChIKey | VWJGWKZZFZMGGY-UHFFFAOYSA-N |
| Solubility | Soluble in DMSO (10 mm) |
| Appearance | Colorless Liquid |
| LogP | -0.71 |
| Storage | Store at 2-8°C, keep in dry and avoid sunlight |
| XLogP3 | 0.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 12 |
| Exact Mass | 247.11682065 g/mol |
| Monoisotopic Mass | 247.11682065 g/mol |
| Topological Polar Surface Area | 79.4Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 243 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2023275025-A1 | Conjugates comprising phosphoantigens and their use in therapy | 2021-06-28 |
| WO-2020163170-A1 | Trapping-free parp inhibitors | 2019-02-05 |
| US-2022098196-A1 | Trapping-free parp inhibitors | 2019-02-05 |
| WO-2020073345-A1 | Conjugation linkers containing 2,3-diaminosuccinyl group | 2018-10-12 |
| AU-2018445278-A1 | Conjugation linkers containing 2,3-diaminosuccinyl group | 2018-10-12 |
Recommended Services
Recommended Articles
- Hoechst Dyes: Definition, Structure, Mechanism and Applications
- Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
- Fluorescent Probes: Definition, Structure, Types and Application
- Fluorescent Dyes: Definition, Mechanism, Types and Application
- Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
- BODIPY Dyes: Definition, Structure, Synthesis and Uses
- Cyanine Dyes: Definition, Structure, Types and Uses
- Fluorescein Dyes: Definition, Structure, Synthesis and Uses
- Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
- Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
- Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
- Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
- Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
- DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
- Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
- Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
- Fluorescent Labeling: Definition, Principles, Types and Applications
Recommended Products
Online Inquiry
